Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS
· Real-Time Price · USD
8.16
0.00 (0.00%)
At close: Jun 24, 2025, 3:59 PM
Regulus Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -47.52M | -46.36M | -41.63M | -35.39M | -31.37M | -30.04M | -28.77M | -28.5M | -28.74M | -28.32M | -28.66M | -29.74M | -28.51M | -27.81M | -22M | -14.89M | -15.81M |
Depreciation & Amortization | -1.02M | -825K | -836K | 302K | 260K | 227K | 184K | 160K | 144K | 122K | 130K | 136K | 150K | 459K | 523K | 599K | 676K |
Stock-Based Compensation | 9M | 7.74M | 6.31M | 4.86M | 3.38M | 2.8M | 2.16M | 1.55M | 1.59M | 2.18M | 2.45M | 2.9M | 3.23M | 2.92M | 2.72M | 2.61M | 2.48M |
Other Working Capital | -259K | -1.96M | 653K | -2.21M | 339K | 228K | -179K | -253K | -88K | 660K | -1.29M | 1.49M | 1.11M | 1.16M | 2.76M | 73K | 733K |
Other Non-Cash Items | 681K | 1.79M | 3.73M | 3.85M | 2.75M | 1.62M | -44K | -77K | -115K | -52K | 56K | 74K | 74K | 46K | 45K | 33K | 59K |
Deferred Income Tax | n/a | n/a | -1.58M | -1.63M | -1.63M | -1.63M | -51K | n/a | n/a | n/a | n/a | n/a | -662K | -662K | -662K | -662K | n/a |
Change in Working Capital | 282K | -1.22M | 846K | -1.97M | 164K | 257K | -376K | -486K | -132K | 550K | -1.08M | 697K | 922K | 914K | 6.26M | 273K | 344K |
Operating Cash Flow | -43.54M | -41.67M | -35.95M | -32.78M | -27.4M | -26.77M | -26.9M | -27.35M | -27.26M | -25.53M | -27.1M | -25.93M | -24.8M | -24.13M | -13.11M | -12.04M | -12.24M |
Capital Expenditures | 157K | -340K | -411K | -924K | -841K | -613K | -605K | -67K | -260K | -361K | -339K | -362K | -300K | -251K | 27K | 53K | 184K |
Cash Acquisitions | n/a | n/a | 3K | 3K | 3K | 3K | 5M | n/a | n/a | n/a | -5M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -5.33M | -83.64M | -83.65M | -83.22M | -83.22M | -4.9M | -7.37M | -20.33M | -32.76M | -32.76M | -30.29M | -12.43M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 69.5M | 48M | 29M | 5M | 5M | 20M | 28M | 33M | 33M | 18M | 5M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -268K | -78.31M | -78.31M | -78.31M | -78.31M | 15.1K | -4.99M | 15K | 2.57K | -12.43K | 4.99M | -12.43K | n/a | n/a | -11K | -22K | -22K |
Investing Cash Flow | 64.06M | -35.98M | -55.05M | -79.14M | -79.05M | 14.49M | 20.03M | 12.61M | -19K | -15.12M | -25.63M | -12.79M | -300K | -251K | 16K | 31K | 162K |
Debt Repayment | -551K | -1.38M | -2.2M | -3.03M | -3.3M | -3.3M | -2.48M | -1.65M | -826K | n/a | 1K | -8K | -8K | -80K | -9.15M | -10.21M | -9.62M |
Common Stock Repurchased | n/a | n/a | n/a | -74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 2K | 2K | 2K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 27K | 32K | 32K | 31K |
Financial Cash Flow | -643K | 92.42M | 91.54M | 91.78M | 105.73M | 11.82M | 12.69M | 16.89M | 3.69M | 4.5M | 36.9M | 32.41M | 47.4M | 53.74M | 31.39M | 30.32M | 15.92M |
Net Cash Flow | 19.87M | 14.76M | 540K | -20.14M | -722K | -461K | 5.82M | 2.14M | -23.59M | -36.16M | -15.83M | -6.32M | 22.3M | 29.36M | 18.07M | 18.08M | 3.61M |
Free Cash Flow | -43.39M | -42.01M | -36.36M | -33.7M | -28.24M | -27.38M | -27.5M | -27.42M | -27.52M | -25.89M | -27.44M | -26.3M | -25.1M | -24.38M | -13.08M | -11.99M | -12.06M |